ODIN – CNS Disorders
Forecasted
ODIN – CNS Disorders supports academic researchers working with pharmaceutical and biotech partners on open, early-stage CNS research to address unmet medical needs and advance drug discovery and diagnostics.
Funder: Lundbeck Foundation
Due Dates (Anticipated): December 2026 (Application deadline)
Funding Amounts: Up to DKK 6.5 million for up to 3 years (new projects); up to DKK 1.5 million for up to 1 year (ODIN top-ups)
Summary: Supports open, precompetitive CNS research co-created by academic researchers and pharmaceutical or biotech partners to address unmet medical needs.
Key Information: Projects must be led by a tenured employee at an ODIN partner university and openly share all newly generated knowledge.
Description
ODIN – CNS Disorders is funded by the Lundbeck Foundation within the Open Discovery Innovation Network, a collaboration platform connecting academic researchers with pharmaceutical and biotech partners. It funds the academic component of joint research projects addressing unmet medical needs, with an emphasis on early-stage, exploratory work relevant to drug discovery and diagnostics. Projects are intended to strengthen translational research and lay the groundwork for new treatments, diagnostics, tools, and technologies.
CNS disorders joined ODIN’s scientific scope in 2026. The wider network also covers cardiometabolic and cardiovascular diseases, infectious diseases, regenerative medicine, and disease-agnostic platform technologies and research tools. ODIN encourages highly innovative, high-risk research through equal collaborations between academia and industry. Its open research model makes project-generated knowledge and results publicly available for further research and commercial use.
